Table 2.
Annexin-V analysis of apoptosis in peripheral lymphocyte sub-populations from South African rheumatoid arthritis patients and race-matched controls ex vivo
Cell population | Patients [Mean % (SEM)] | Controls [Mean % (SEM)] |
---|---|---|
Total PBL | 30.0 (1.5)* | 7.2 (0.9) |
CD4+ PBL | 26.3 (1.6)* | 7.6 (0.8) |
CD19+ PBL | 60.5 (7.4)* | 16.1 (1.9) |
* Significant difference (p < 0.05; Mann-Whitney test). CD4, cytotoxic T-lymphocyte marker; CD19, pan B-lymphocyte marker.